Dive Brief: Karuna Therapeutics has submitted an application seeking Food and Drug Administration approval of KarXT, a drug that works in a new way to...

Dive Brief: A new cancer drug developed by Daiichi Sankyo and AstraZeneca met one of its two main goals in a breast cancer trial, helping...

The Food and Drug Administration's decision last month not to approve a new treatment for one of the most common forms of depression was,...

Publicly traded Veritiv Corporation, a provider of packaging, janitorial and sanitary, and hygiene products, has agreed to be acquired by Clayton, Dubilier & Rice...

Apollo has completed its acquisition of Univar Solutions, a distributor of commodity and specialty chemicals, at an enterprise value of $8.1 billion. Co-investing on...

Biogen shareholders elected a new member to the company’s board of directors on Monday, marking the latest in a series of management changes that...

The clock is ticking on Boeing Co.’s plan to hike output of its best-selling jet, as a key supplier heads back to the bargaining...

The first gene therapy for Duchenne muscular dystrophy will cost $3.2 million, its developer, biotechnology company Sarepta Therapeutics, said on Thursday. The price makes the...

Avid Bioservices Inc. (NASDAQ: CDMO) Q4 2023 earnings call dated Jun. 21, 2023Corporate Participants: Tim Brons — Investor Relations Nicholas Green — President and Chief Executive Officer Daniel Hart — Chief Financial Officer Matthew...

Shares of UniQure lost more than a third of their value Wednesday morning after the Netherlands-based biotechnology company announced mixed results from a key...

Dive Brief: The Food and Drug Administration has paused a Phase 2 trial of a cell therapy Arcellx is developing for multiple myeloma following the...

Three members of Biogen’s board of directors will step down, changes that, to some who closely follow the company, indicate its historically at-odds boardroom...